Holen Sie sich die Stockscreener-App
32.03
2.47%
-0.8148
Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.17%
46.75
|
44.45 | 60.11 | 45.17 | 35.36 |
| Operating Income/Loss |
5.17%
-46.75
|
-44.45 | -60.11 | -45.17 | -35.36 |
| Nonoperating Income/Loss |
55.28%
3.472
|
2.236 | 3.764 | 4.154 | 3.854 |
| Income/Loss From Continuing Operations Before Tax |
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
| Income/Loss From Continuing Operations After Tax |
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
|
Net Income/Loss
|
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
23.11%
65.45
|
53.16 | 49.82 | 49.36 | 44.90 |
| Diluted Average Shares |
23.11%
65.45
|
53.16 | 49.82 | 49.36 | 44.90 |
| Basic Earnings Per Share |
16.46%
-0.66
|
-0.79 | -1.13 | -0.83 | -0.70 |
| Diluted Earnings Per Share |
16.46%
-0.66
|
-0.79 | -1.13 | -0.83 | -0.70 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.79%
3.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):